drug
ataciguat
Phase 3updated 3mo agoby Kardigan Inc
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ataciguat
News(1)
- Kardigan extends biotech’s streak of big IPOs with $400M haulIncluding the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to BioPharma Dive data.biopharma_dive · 2mo ago
Data sources
last refreshed 22m ago
Found something off?
comments(0)
5-min edit window · permanent after that